Open Beta
TREN
MetriLume
TREN

US marketsPLRX

SEC-sourced researchBeta

PLRX

PLIANT THERAPEUTICS, INC.

Company comparison ↗

Data passport

CIK
0001746473
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 0.0000 USD0 USD0 USD0December 2024December 2025
PLRX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 11, 2026
December 20250.0000Mar 11, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20250.0000-149,344,000.0000-128,336,000.0000225,228,000.000044,023,000.0000Mar 11, 2026
December 20240.0000-210,304,000.0000-155,503,000.0000396,949,000.000092,868,000.0000Mar 11, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2025Mar 11, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2024Mar 11, 202610-K
Net incomeNetIncomeLoss-$149.34MDecember 2025Mar 11, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$128.34MDecember 2025Mar 11, 202610-K
Total assetsAssets$225.23MDecember 2025Mar 11, 202610-K
Total liabilitiesLiabilities$44.02MDecember 2025Mar 11, 202610-K

New filings

Explore methodology ↗